Frontiers in Oncology | Cancer Immunity and Immunotherapy

Correction

Published on 27 Feb 2024

Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

in Cancer Immunity and Immunotherapy

Youlong Wang
Qi Huang
Guanqing Zhong
Jun Lv
Qinzhi Guo
Yifei Ma
Xinjia Wang
Jiling Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1376408

854 views

Review

Published on 26 Feb 2024

Biopterin metabolism and nitric oxide recoupling in cancer

in Cancer Immunity and Immunotherapy

Gene Chatman Clark
Alan Lai
Aashri Agarwal
Zheng Liu
Xiang-Yang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1321326

1,796 views
1 citation

Mini Review

Published on 26 Feb 2024

Current therapies and progress in the treatment of advanced gastric cancer

in Cancer Immunity and Immunotherapy

Hongyu Li
Ming Shen
Shihao Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1327055

4,442 views
4 citations

Original Research

Published on 23 Feb 2024

Machine learning-based identification of colorectal advanced adenoma using clinical and laboratory data: a phase I exploratory study in accordance with updated World Endoscopy Organization guidelines for noninvasive colorectal cancer screening tests

in Cancer Immunity and Immunotherapy

Huijie Wang
Xu Cao
Ping Meng
Caihua Zheng
Jinli Liu
Yong Liu
Tianpeng Zhang
Xiaofang Li
Xiaoyang Shi
Xiaoxing Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1325514

1,859 views
1 citation

Brief Research Report

Published on 21 Feb 2024

Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Pamela Winnie M. Maimela
Muneerah Smith
Andrew J. M. Nel
Suba Dharshanan P. Bernam
Eduard G. Jonas
Jonathan M. Blackburn

Frontiers in Oncology

doi 10.3389/fonc.2024.1330419

2,104 views
1 citation

Editorial

Published on 20 Feb 2024

Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis

in Cancer Immunity and Immunotherapy

Tabea Gewalt
Linda Diehl
Lydia Meder

Frontiers in Oncology

doi 10.3389/fonc.2024.1373308

789 views

Original Research

Published on 20 Feb 2024

Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers

in Cancer Immunity and Immunotherapy

Douglas I. Lin
Richard S. P. Huang
Ioannis Ladas
Rachel B. Keller
Nimesh R. Patel
Sotirios Lakis
Brennan Decker
Tyler Janovitz
Douglas A. Mata
Jeffrey S. Ross

Frontiers in Oncology

doi 10.3389/fonc.2024.1328512

3,100 views
2 citations

Original Research

Published on 15 Feb 2024

PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer

in Cancer Immunity and Immunotherapy

Ahmad Reza Panahi Meymandi
Behnia Akbari
Tahereh Soltantoyeh
Zahra Shahosseini
Mina Hosseini
Jamshid Hadjati
Hamid Reza Mirzaei

Frontiers in Oncology

doi 10.3389/fonc.2024.1357801

2,762 views
4 citations

Study Protocol

Published on 12 Feb 2024

Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

in Cancer Immunity and Immunotherapy

Susanne Jung
Richard F. Schlenk
Christopher Hackenbruch
Sandra S.L. Roldan Pinzon
Michael Bitzer
Martin Pflügler
Juliane S. Walz
Gundram Jung
Jonas S. Heitmann
Helmut R. Salih

Frontiers in Oncology

doi 10.3389/fonc.2024.1351901

2,217 views

Case Report

Published on 12 Feb 2024

Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma

in Cancer Immunity and Immunotherapy

Samantha Su Ping Low
Karim El-Shakankery
Ewan Brown
Alan Christie
Sally McCormack
Mark Stares

Frontiers in Oncology

doi 10.3389/fonc.2024.1330271

1,485 views
1 citation

Original Research

Published on 08 Feb 2024

Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Jiaxin Wang
Huaijuan Guo
Jingjing Yang
Jingxian Mao
Ying Wang
Xuebing Yan
Hong Guo

Frontiers in Oncology

doi 10.3389/fonc.2024.1339729

1,493 views
1 citation

Review

Published on 07 Feb 2024

Modern cancer therapy: cryoablation meets immune checkpoint blockade

in Cancer Immunity and Immunotherapy

Qi Liu
Chunyang Zhang
Xuxin Chen
Zhihai Han

Frontiers in Oncology

doi 10.3389/fonc.2024.1323070

3,043 views
5 citations

Original Research

Published on 05 Feb 2024

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer

in Cancer Immunity and Immunotherapy

Yimeng Sun
Xiaoyan Wang
Lin Yao
Rong He
Changfeng Man
Yu Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1246308

2,096 views
2 citations

Case Report

Published on 31 Jan 2024

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

in Cancer Immunity and Immunotherapy

Zhen-feng Zhu
Xu-xia Bao
Hong-yan Shi
Xi-xi Gu

Frontiers in Oncology

doi 10.3389/fonc.2024.1283008

2,066 views

Review

Published on 24 Jan 2024

Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells

in Cancer Immunity and Immunotherapy

Ameneh Jafari
Masoumeh Farahani
Meghdad Abdollahpour-Alitappeh
Asma Manzari-Tavakoli
Mohsen Yazdani
Mostafa Rezaei-Tavirani

Frontiers in Oncology

doi 10.3389/fonc.2023.1277772

4,023 views
6 citations

Original Research

Published on 18 Jan 2024

Cost-effectiveness analysis of toripalimab for metastatic or recurrent triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Jiangbo Shao
Cuiping Zhan
Chunxiang Jin
Ying Jin

Frontiers in Oncology

doi 10.3389/fonc.2023.1268584

2,152 views

Navigation group

Articles

Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

Biopterin metabolism and nitric oxide recoupling in cancer

Current therapies and progress in the treatment of advanced gastric cancer

Machine learning-based identification of colorectal advanced adenoma using clinical and laboratory data: a phase I exploratory study in accordance with updated World Endoscopy Organization guidelines for noninvasive colorectal cancer screening tests

Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma

Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis

Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers

PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer

Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

Case report: A rare case of immunotherapy induced isolated left CN VI palsy in a patient with unresectable melanoma

Identification of C-PLAN index as a novel prognostic predictor for advanced lung cancer patients receiving immune checkpoint inhibitors

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer

Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy

Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells

Cost-effectiveness analysis of toripalimab for metastatic or recurrent triple-negative breast cancer